BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.62
+0.14 (1.65%)
At close: Mar 9, 2026, 4:00 PM EDT
8.59
-0.03 (-0.35%)
After-hours: Mar 9, 2026, 7:17 PM EDT
BioCryst Pharmaceuticals Revenue by Type
History
| Date | Collaborative and Other | Product |
|---|---|---|
| Dec 31, 2025 | 251.69M | 623.15M |
| Sep 30, 2025 | 6.52M | 593.30M |
| Jun 30, 2025 | 5.88M | 551.63M |
| Mar 31, 2025 | 6.30M | 497.18M |
| Dec 31, 2024 | 8.04M | 442.67M |
| Sep 30, 2024 | 8.52M | 404.06M |
| Jun 30, 2024 | 8.95M | 373.29M |
| Mar 31, 2024 | 9.59M | 345.80M |
| Dec 31, 2023 | 6.72M | 324.70M |
| Sep 30, 2023 | 5.54M | 312.02M |
| Jun 30, 2023 | 4.70M | 301.95M |
| Mar 31, 2023 | 3.35M | 286.33M |
| Dec 31, 2022 | 3.12M | 267.71M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.